Trump has repeatedly mentioned these new anti virals, we won't know who is getting the money until it's been dispersed and I am assuming it will go along the same route that companies will have to apply for the money. If DRACO doesn't apply they won't get a cut.

We also have to remember that each virus mutates and because one therapeutic works for one strain that may not hold true for a future strain. They also mentioned they are still in their clinical trial period. Regardless it seems like they are on the right track and if they go successfully through their trial periods they should have no problem bringing their product to market.